Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Update on Kaposi's sarcoma].

J J Morand1, E Lightburn, F Simon

  • 1Service de dermatologie Médecin, HIA Laveran, Marseille, France. MorandJJ@aol.com

Medecine Tropicale : Revue Du Corps De Sante Colonial
|August 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of infectious diseases during military deployments: a review of the French armed forces strategy.

Travel medicine and infectious disease·2014
Same author

Recent advances in heartworm disease.

Veterinary parasitology·2014
Same author

Seroprevalence of heartworm (Dirofilaria immitis) in feline and canine hosts from central and northern Portugal.

Journal of helminthology·2014
Same author

Observation of D0-D0 mixing in e+e- collisions.

Physical review letters·2014
Same author

Proteomic analysis of the somatic and surface compartments from Dirofilaria immitis adult worms.

Veterinary parasitology·2014
Same author

Measurement of the τ-lepton lifetime at Belle.

Physical review letters·2014
Same journal

[Physiopathology of chronic arthritis following chikungunya infection in man].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Judicial or administrative settlement of medical malpractice claims. Update on medical liability].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Chikungunya epidemic in 2005-2006: questions from occupational health professionals].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Administrative issues linked to health insurance coverage of chronic post-chikungunya rheumatism].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Coverage of the chikungunya epidemic on Reunion Island in 2006 by the French healthcare system].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Five-year outcome of mother-to-child transmission of chikungunya virus].

Medecine tropicale : revue du Corps de sante colonial·2012
See all related articles

Kaposi's sarcoma (KS), a tumor of blood and lymphatic vessels, is linked to human herpesvirus 8 (HHV8). While HAART has reduced KS incidence in developed nations, it remains prevalent in developing countries, highlighting the need for new treatments.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Context:

  • Kaposi's sarcoma (KS) is a complex mesenchymal tumor.
  • It is associated with human herpesvirus 8 (HHV-8) and viral growth factors like IL-6.
  • KS presents in various forms, including classic, iatrogenic, endemic, and AIDS-related KS.

Purpose:

  • To provide a comprehensive review of Kaposi's sarcoma.
  • To cover its epidemiology, pathogenesis, clinical spectrum, histology, staging, and treatment.
  • To highlight the disparity in AIDS-KS incidence between industrialized and developing countries.

Summary:

  • KS is a mesenchymal tumor of blood and lymphatic vessels, driven by HHV-8.
  • The review details KS subtypes, diagnostic criteria, and therapeutic approaches.

Related Experiment Videos

  • Highly active antiretroviral therapy (HAART) has decreased KS prevalence in industrialized nations, but not in developing countries.

    • Impact:

    • Identifies current challenges in KS management, particularly in resource-limited settings.
    • Suggests future therapeutic strategies focusing on immune enhancement and anti-angiogenesis.
    • Aims to improve understanding and treatment outcomes for Kaposi's sarcoma patients globally.